Latest Insider Transactions at Horizon Therapeutics Public LTD CO (HZNP)
This section provides a real-time view of insider transactions for Horizon Therapeutics Public LTD CO (HZNP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Horizon Therapeutics Public Ltd Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Horizon Therapeutics Public Ltd Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Indirect |
172,226
-70.29%
|
-
|
|
Mar 07
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Direct |
66,626
-98.45%
|
-
|
|
Mar 02
2022
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
35,000
-13.63%
|
$3,395,000
$97.24 P/Share
|
|
Feb 28
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-2.19%
|
$4,600,000
$92.01 P/Share
|
|
Feb 25
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-4.09%
|
$2,300,000
$92.51 P/Share
|
|
Feb 25
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.93%
|
$550,000
$22.14 P/Share
|
|
Feb 18
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,313
-3.2%
|
$123,422
$94.82 P/Share
|
|
Feb 11
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.06%
|
$2,425,000
$97.53 P/Share
|
|
Feb 11
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.93%
|
$550,000
$22.14 P/Share
|
|
Feb 01
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,767
-8.43%
|
$354,098
$94.33 P/Share
|
|
Feb 01
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,087
+16.9%
|
-
|
|
Jan 31
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
100,000
-5.02%
|
$9,100,000
$91.77 P/Share
|
|
Jan 28
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-3.52%
|
$2,250,000
$90.0 P/Share
|
|
Jan 28
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.4%
|
$550,000
$22.14 P/Share
|
|
Jan 21
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,009
-1.3%
|
$774,774
$86.42 P/Share
|
|
Jan 21
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,336
+2.84%
|
-
|
|
Jan 21
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,372
-3.85%
|
$203,992
$86.42 P/Share
|
|
Jan 21
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,354
+7.99%
|
-
|
|
Jan 21
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,463
-3.51%
|
$211,818
$86.42 P/Share
|
|
Jan 21
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,558
+7.34%
|
-
|
|
Jan 21
2022
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,825
-1.31%
|
$156,950
$86.42 P/Share
|
|
Jan 21
2022
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,679
+2.57%
|
-
|
|
Jan 14
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-3.58%
|
$2,250,000
$90.02 P/Share
|
|
Jan 14
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.45%
|
$550,000
$22.14 P/Share
|
|
Jan 06
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
7,987
-4.2%
|
$782,726
$98.93 P/Share
|
|
Jan 05
2022
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,841
-26.51%
|
$5,033,941
$101.84 P/Share
|
|
Jan 05
2022
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,375
+20.13%
|
-
|
|
Jan 05
2022
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,959
+31.6%
|
-
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,636
-9.27%
|
$367,236
$101.84 P/Share
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,043
+17.01%
|
-
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
174,906
-20.6%
|
$17,665,506
$101.84 P/Share
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
152,896
+15.26%
|
-
|
|
Jan 05
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
241,750
+25.77%
|
-
|
|
Jan 05
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,675
-40.09%
|
-
|
|
Jan 05
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,301
+25.58%
|
-
|
|
Jan 05
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,570
+46.01%
|
-
|
|
Jan 05
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,666
-43.96%
|
$5,117,266
$101.84 P/Share
|
|
Jan 05
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
47,375
+29.13%
|
-
|
|
Jan 05
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
66,822
+49.61%
|
-
|
|
Jan 05
2022
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
41,276
-23.32%
|
$4,168,876
$101.84 P/Share
|
|
Jan 05
2022
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
32,301
+15.43%
|
-
|
|
Jan 05
2022
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
53,734
+27.08%
|
-
|
|
Jan 05
2022
|
Elizabeth H.Z. Thompson EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,030
-24.94%
|
$710,030
$101.84 P/Share
|
|
Jan 05
2022
|
Elizabeth H.Z. Thompson EVP, Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,999
+33.18%
|
-
|
|
Jan 05
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,710
-30.72%
|
$2,192,710
$101.84 P/Share
|
|
Jan 05
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,839
+40.87%
|
-
|
|
Jan 05
2022
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,175
-14.92%
|
$825,675
$101.84 P/Share
|
|
Jan 05
2022
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,289
+25.02%
|
-
|
|
Dec 31
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
75,000
-7.19%
|
$8,100,000
$108.29 P/Share
|
|
Dec 31
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.51%
|
$550,000
$22.14 P/Share
|